Abstract Recombinant interferon (IFN) β-1b was approved by the US Food and Drug
Administration as the first disease-modifying therapy (DMT) for multiple sclerosis (MS) in …

Objective To develop a valid algorithm for identifying multiple sclerosis (MS) cases in
administrative health claims (AHC) datasets. Methods We used 4 AHC datasets from the …

Objective: To design and perform a case-control study of multiple sclerosis (MS) in Crete, an
island of 0.6 million people, that has experienced profound socioeconomic changes in …

Cladribine is a purine nucleoside analog initially developed in the 1970s as a treatment for
various blood cancers. Due to the molecule's ability to preferentially reduce T and B …

Background While mental comorbidity is considered common in multiple sclerosis (MS), its
impact is poorly defined; methods are needed to support studies of mental comorbidity. We …

Objective: We aimed to evaluate the association between comorbidity and rates of
hospitalization in the multiple sclerosis (MS) population as compared to a matched cohort …

Few studies have assessed the risk of adverse pregnancy outcomes in women with multiple
sclerosis (MS). We used 2 large US administrative databases, the Truven Health …

Background: There is increasing evidence of prodromal multiple sclerosis (MS). Objective:
The aim of this study was to determine whether fatigue, sleep disorders, anaemia or pain …

Objective: We aimed to describe hospitalizations in the multiple sclerosis (MS) population,
and to evaluate temporal trends in hospitalizations in the MS population compared to the …

Importance Epstein-Barr virus and its acute manifestation, infectious mononucleosis (IM),
are associated with an increased risk of multiple sclerosis (MS). Whether this association is …